Company Profile
FEMASYS Stock Price, News & Catalysts
- Ticker:
- FEMY
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.10 USD (-2.78%)
Close
Last updated: October 1, 2026
22.4M USD
Market cap
Why the stock is moving
As of Oct 1, 2026, FEMY closed down 2.78% at $2.10. No new same-company headline was identified in the current news window.
Company overview
Women's Health Medical Device Company
Femasys develops office-based products for reproductive health. Its portfolio addresses permanent contraception, infertility treatment, and diagnostic evaluation of the uterus and fallopian tubes.
FemBloc Permanent Contraception
FemBloc is a non-surgical permanent birth-control system delivered through the fallopian tubes in a physician's office. The product is designed to avoid surgical incisions, general anesthesia, and implanted metal devices.
FINALE Pivotal Program
The FINALE study is the final stage of the U.S. pivotal clinical program for FemBloc. The trial is intended to provide the effectiveness and safety evidence needed for a future FDA submission.
FemaSeed Fertility Treatment
FemaSeed delivers sperm directly into a selected fallopian tube, closer to the site of fertilization than standard intrauterine insemination. It is positioned as an office-based option before more invasive assisted-reproduction procedures.
Diagnostic Product Portfolio
FemVue and FemCath products help physicians evaluate fallopian-tube patency and the uterine cavity. These commercial devices provide an established channel with obstetricians, gynecologists, and fertility specialists.
Future catalysts
- Completion of the pivotal FINALE study of FemBloc to support a future U.S. regulatory submission.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of FEMASYS (FEMY)?
FEMASYS (FEMY) most recently closed at 2.10 USD, a -2.78% move versus the previous session.
What is the market cap of FEMASYS (FEMY)?
FEMASYS currently has a market capitalization of 22.4M USD on BioPharmSignal.
What does FEMASYS do?
Women's Health Medical Device Company Femasys develops office-based products for reproductive health. Its portfolio addresses permanent contraception, infertility treatment, and diagnostic evaluation of the uterus and fallopian tubes. FemBloc Permanent Contraception FemBloc is a non-surgical permanent birth-control system delivered through the fallopian...
On which exchange is FEMY stock listed?
FEMASYS (FEMY) is associated with NASDAQ, United States, Biopharma.
What is Women?
Women's Health Medical Device Company Femasys develops office-based products for reproductive health.
Which conditions is FEMASYS targeting with Women?
Women's Health Medical Device Company Femasys develops office-based products for reproductive health. Its portfolio addresses permanent contraception, infertility treatment, and diagnostic evaluation of the uterus and fallopian tubes. FemBloc Permanent Contraception FemBloc is a non-surgical permanent birth-control system delivered through the fallopian...
How does FEMASYS describe recent progress with Women?
Completion of the pivotal FINALE study of FemBloc to support a future U.S. regulatory submission.
What is Health?
Women's Health Medical Device Company Femasys develops office-based products for reproductive health.